Related Experiment Videos
[Preclinical assay on a magnetic carrier type ferrofluid]
O Bredeţean1, Al D Ciochină, Gh Iacob
1Facultatea de Bioinginerie Medicală Disciplina de Farmacologie, Toxicologie şi Farmacologie Clinică, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
Summary
This study found that the ferrofluid, a magnetic carrier, has a lethal dose of 30 mg iron/100 g body weight in mice and no antibacterial activity. Ammonium ions may cause toxicity.
Area of Science:
- Biomedical Engineering
- Materials Science
- Toxicology
Context:
- Ferrofluids, composed of magnetic nanoparticles like Fe3O4, are utilized in various biomedical applications.
- Understanding the biocompatibility and potential toxicity of novel ferrofluid formulations is crucial for their safe application.
- This study investigates a specific hydrophilic ferrofluid prepared with ammoniumoleate-coated Fe3O4 nanoparticles.
Purpose:
- To evaluate the acute toxicity of a novel ferrofluid in a murine model.
- To determine the antimicrobial properties of the ferrofluid against common bacterial strains.
- To establish the maximum tolerated dose (MTD) and lethal dose 100 (LD100) of the ferrofluid.
Summary:
- Acute toxicity testing in Swiss male mice revealed an LD100 of 0.75 ml (30 mg iron/100 g body weight) and an MTD of 0.25 ml (10 mg iron/100 g body weight).
- Mortality in mice occurred between 24 and 96 hours post-intraperitoneal administration.
- No in vitro antibacterial activity was observed against E. coli, Klebsiella spp., Staphylococcus aureus, or Streptococcus group D.
Impact:
- The findings indicate potential toxicity associated with the ammonium ions released from the ammoniumoleate coating.
- This research provides critical toxicological data for the development and application of Fe3O4-based ferrofluids.
- The lack of observed antibacterial effects suggests this ferrofluid is not suitable for antimicrobial applications.